Fed Regist. 2000 Aug 29;65(168):52302-5.
The Food and Drug Administration (FDA) is issuing a final rule amending the monograph for over-the-counter (OTC) topical antifungal drug products. The amendment makes a minor change in the indications for these drug products. This final rule is part of the ongoing review of OTC drug products conducted by FDA.
美国食品药品监督管理局(FDA)正在发布一项最终规则,修订非处方(OTC)外用抗真菌药品的专论。该修订对这些药品的适应症做了细微更改。这项最终规则是FDA对非处方药品持续审查的一部分。